A pilot study of extended duration peginterferon alfa-2a for patients with hepatitis B e antigen-negative chronic hepatitis B.
about
Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions.Pros and Cons of Peginterferon Versus Nucleos(t)ide Analogues for Treatment of Chronic Hepatitis B.Precise prediction model and simplified scoring system for sustained combined response to interferon-alpha.Current status of antiviral therapy for hepatitis BOptimization of adefovir therapy in chronic hepatitis B according to baseline predictors and on-treatment HBV DNA: a 5-year prospective studyIschemic colitis during interferon-ribavirin therapy for chronic hepatitis C: a case report.Efficacy of peginterferon α-2a and predictors of response in HBeAg-negative, genotype D-naive patientsKinetics of Hepatitis B Surface Antigen Level in Chronic Hepatitis B Patients who Achieved Hepatitis B Surface Antigen Loss during Pegylated Interferon Alpha-2a Treatment.Antiviral drugs for HBV liver disease.Why do I treat HBeAg-negative chronic hepatitis B patients with pegylated interferon?PegIFN-α2a for the treatment of chronic hepatitis B and C: a 10-year history.HBeAg-negative chronic hepatitis B: why do I treat my patients with pegylated interferon-alfa?On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients.A randomized trial of peginterferon alpha-2a with or without ribavirin for HBeAg-negative chronic hepatitis B.Extended peginterferon alfa-2a (Pegasys) therapy in Chinese patients with HBeAg-negative chronic hepatitis B.Efficacy of sequential use of telbivudine in hepatitis B e antigen-positive chronic hepatitis B patients with partial responses to pegylated interferon: a pilot study.Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels.Association of on-treatment serum hepatitis B surface antigen level with sustained virological response to nucleos(t)ide analog in patients with hepatitis B e-antigen positive chronic hepatitis B.Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B.Hepatitis B surface antigen quantification as a current-day paradox: obtaining the gold in the face of diminishing returns.Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patientsHepatitis B: Prognosis and Treatment
P2860
Q33718958-86B045F0-96FD-470B-9E36-3EF237A90576Q33819124-EF6162D2-1A78-4A96-BEDF-B152683A851FQ33998692-9BC2A2C6-CD39-42DE-A1C6-C43DF7791CE7Q34408879-A5117A17-CFA0-4738-BDF5-2DF521B42443Q35487430-78584D60-8A5B-4AF9-A4D7-08D1E21F82F0Q36175105-EFB63B2C-398E-4D44-8355-5DFA730F5FEDQ37072918-BEB60138-06E2-4225-B2B5-B12900B78B6FQ37684139-6C000830-5FBB-4849-9FE0-E6DCEA5DE83CQ37825909-C5EFD5F0-3102-426D-A272-D1486ED8532AQ38071402-26B945FC-8A30-4C24-AFB0-CE573D8BD34EQ38102776-7D134A0B-97BF-4FD4-ABD0-4D53B10A1D6DQ38174261-3261F32A-C99A-460D-ADC3-47FDEEEA63E7Q38421350-AF4C87B8-80D3-4F6C-9736-D9521FE38750Q42165788-753AE1EE-0790-40F8-9C87-06F12436C8F5Q42209104-B2333DB0-31C9-410C-AAD8-C4F9D0D2F979Q42271417-716A98A4-1ABA-46AC-B13F-2D1540743FDFQ42947260-ACA55D7F-0493-4846-9835-EF9612399325Q45067577-015A1B1F-04ED-4DD4-96A7-259375E728E6Q45385574-CD416FF4-CB64-4A76-936A-9E40A35C3986Q51745474-54C5A638-CD58-48F6-B011-790D70388120Q57782730-A332965C-C98C-453B-AF02-B2644445A07EQ58803261-B5D0C28A-C49B-4F30-B54B-5F36307F3790
P2860
A pilot study of extended duration peginterferon alfa-2a for patients with hepatitis B e antigen-negative chronic hepatitis B.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
A pilot study of extended dura ...... -negative chronic hepatitis B.
@en
A pilot study of extended dura ...... -negative chronic hepatitis B.
@nl
type
label
A pilot study of extended dura ...... -negative chronic hepatitis B.
@en
A pilot study of extended dura ...... -negative chronic hepatitis B.
@nl
prefLabel
A pilot study of extended dura ...... -negative chronic hepatitis B.
@en
A pilot study of extended dura ...... -negative chronic hepatitis B.
@nl
P2093
P2860
P1476
A pilot study of extended dura ...... -negative chronic hepatitis B.
@en
P2093
Daryl T-Y Lau
Peter Schmid
Robert G Gish
Robert Perrillo
P2860
P304
P356
10.1111/J.1572-0241.2007.01449.X
P407
P577
2007-07-27T00:00:00Z